Literature DB >> 8401912

Tachykinin receptors mediating responses to sensory nerve stimulation and exogenous tachykinins and analogues in the rabbit isolated iris sphincter.

J M Hall1, D Mitchell, I K Morton.   

Abstract

1. We have used selective tachykinin receptor agonists and antagonists to investigate the nature of the receptors mediating responses to endogenous and exogenous tachykinins in the rabbit iris sphincter preparation in vitro. 2. The NK1-selective agonist, substance P methyl ester, induced contraction with a pD2 of 9.16 indicating the presence of NK1 receptors. In confirmation, the NK1-selective antagonist, GR82334, competitively antagonized responses to substance P methyl ester with high affinity (pKB 7.46). 3. NK3 receptors also mediate contraction since NK3-selective agonists exhibited high potency, e.g. the pD2 of [Me-Phe7]-neurokinin B was 9.67, and their responses were not inhibited by GR82334 (10 microM). 4. NK2 receptor activation does not seem to contribute to contraction since the NK2-selective agonist [beta-Ala8]-neurokinin A(4-10) had relatively low potency (pD2 6.43), and the NK2-selective antagonists MEN10207 (1 microM) and L-659,877 (10 microM) were inactive or had low affinity, respectively. 5. GR82334 (1 microM) significantly inhibited responses to electrical field-stimulation of non-adrenergic non-cholinergic sensory nerves (3, 10 and 30 Hz), and caused a rightward shift of the log concentration-response curve to bradykinin (lateral shift ca. 1000 fold). Higher concentrations of GR82334 (10 microM) significantly attenuated responses to capsaicin (1-60 microM) whilst completely abolishing responses to field-stimulation (3, 10 and 30 Hz) and bradykinin (1 nM- 3 microM). 6. In conclusion, NK1 and NK3 receptor activation results in contraction of the rabbit iris sphincter. The contractile response following sensory nerve stimulation by bradykinin, capsaicin and electrical field stimulation results from NK1 receptor activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8401912      PMCID: PMC2175754          DOI: 10.1111/j.1476-5381.1993.tb13721.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  A potent and selective agonist for NK-2 tachykinin receptor.

Authors:  P Rovero; V Pestellini; R Patacchini; S Giuliani; P Santicioli; C A Maggi; A Meli; A Giachetti
Journal:  Peptides       Date:  1989 May-Jun       Impact factor: 3.750

2.  Comparison of the responses to the sensory neuropeptides, substance P, neurokinin A, neurokinin B and calcitonin gene-related peptide and to trigeminal nerve stimulation in the iris sphincter muscle of the rabbit.

Authors:  I Muramatsu; S Nakanishi; M Fujiwara
Journal:  Jpn J Pharmacol       Date:  1987-05

3.  The effects of sensory denervation on the responses of the rabbit eye to prostaglandin E1, bradykinin and substance P.

Authors:  J M Butler; B R Hammond
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

Review 4.  Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides.

Authors:  P Holzer
Journal:  Neuroscience       Date:  1988-03       Impact factor: 3.590

5.  Specific agonists for neurokinin B receptors.

Authors:  G Drapeau; P d'Orléans-Juste; S Dion; N E Rhaleb; D Regoli
Journal:  Eur J Pharmacol       Date:  1987-04-29       Impact factor: 4.432

6.  A highly selective NK-2 tachykinin receptor antagonist containing D-tryptophan.

Authors:  P Rovero; V Pestellini; C A Maggi; R Patacchini; D Regoli; A Giachetti
Journal:  Eur J Pharmacol       Date:  1990-01-03       Impact factor: 4.432

7.  Competitive antagonists discriminate between NK2 tachykinin receptor subtypes.

Authors:  C A Maggi; R Patacchini; S Giuliani; P Rovero; S Dion; D Regoli; A Giachetti; A Meli
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

8.  A pharmacological study of NK1 and NK2 tachykinin receptor characteristics in the rat isolated urinary bladder.

Authors:  J M Hall; J M Flowers; I K Morton
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

9.  Tissue selectivity of substance P alkyl esters: suggesting multiple receptors.

Authors:  S P Watson; B E Sandberg; M R Hanley; L L Iversen
Journal:  Eur J Pharmacol       Date:  1983-01-28       Impact factor: 4.432

10.  Evidence for multiple tachykinin receptor subtypes on the rabbit iris sphincter muscle.

Authors:  H P Too; W G Unger; M R Hanley
Journal:  Mol Pharmacol       Date:  1988-01       Impact factor: 4.436

View more
  5 in total

1.  Investigation of the specificity of FK 888 as a tachykinin NK1 receptor antagonist.

Authors:  Z Y Wang; S R Tung; G R Strichartz; R Håkanson
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

2.  Inhibition of bradykinin-evoked trigeminal nerve stimulation by the non-peptide bradykinin B2 receptor antagonist WIN 64338 in vivo and in vitro.

Authors:  J M Hall; M Figini; S K Butt; P Geppetti
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

3.  Non-specific actions of the non-peptide tachykinin receptor antagonists, CP-96,345, RP 67580 and SR 48968, on neurotransmission.

Authors:  Z Y Wang; S R Tung; G R Strichartz; R Håkanson
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

4.  Inhibition by SR 140333 of NK1 tachykinin receptor-evoked, nitric oxide-dependent vasodilatation in the hamster cheek pouch microvasculature in vivo.

Authors:  J M Hall; S D Brain
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

5.  Typical and atypical NK1 tachykinin receptor characteristics in the rabbit isolated iris sphincter.

Authors:  J M Hall; D Mitchell; I K Morton
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.